Vivek Subbiah, MD
@VivekSubbiah
Followers
39K
Following
33K
Media
4K
Statuses
30K
Chief, Early-Phase Drug Development|@SarahCannonDocs #Oncologist, #Phase1trials, #PrecisionMedicine. Tweets=My own.
Nashville, TN, USA
Joined March 2015
Smallpox at the Siege of Boston, November 1775–March 1776 | New England Journal of Medicine
nejm.org
Smallpox played a pivotal role throughout the American Revolution, but the record remains ambiguous about whether British officers weaponized refugees to sow pestilence in the Continental Army.
0
0
1
Simplify or Stratify? The Debate over Medical School Grading Systems | New England Journal of Medicine
nejm.org
This feature about the preclinical grading system in a medical school offers a case vignette accompanied by two essays, one supporting continuation of the five-tier grading system (A, B, C, D, F) a...
1
2
3
Understanding How Aspirin Prevents Metastasis | New England Journal of Medicine
nejm.org
A new study shows that aspirin enhances antimetastatic immunity by decreasing platelet activation, thereby releasing T cells from suppression by thromboxane A2.
0
0
0
Bedside to Bench — AI and the New Science of Medicine | New England Journal of Medicine
nejm.org
Today, medical research builds up an understanding of the whole from molecular parts, but artificial intelligence can revive an approach building down from patient-level data to theory and understa...
0
0
7
Disitamab Vedotin plus Toripalimab in HER2-Expressing Advanced Urothelial Cancer | New England Journal of Medicine
nejm.org
Human epidermal growth factor receptor 2 (HER2)–directed antibody–drug conjugate monotherapy has shown preliminary clinical efficacy in patients with chemotherapy-refractory HER2-positive locally a...
0
1
3
Small space, big comfort. Wayfair has stylish tables and seating that make every corner count.
0
22
480
Amazing work & vision led by @DrChoueiri & @DrRanaMcKay! A million thanks to @CACancerJournal for the opportunity to showcase this ...
The 2025 @AUC3_Official (Advanced Urologic Cancer Consensus Conference) is out in @CACancerJournal (IF:286!). A panel of 51 experts participated in a Delphi process addressing questions developed through consensus-building covering Kidney/Bladder Cancer management.
2
3
28
@Uromigos amazing contributions to the educational mission! Great idea about this academy :-) looking forward to having you in Athens on June 25-27! @TresUramigas @brian_rini @tompowles1 @OncoAlert @shilpaonc @neerajaiims @montypal @VivekSubbiah @TiansterZhang @PavlosMsaouel
Congrats @tompowles1 @brian_rini on forming the @Uromigos 🇨🇳academy to mentor the next generation of Chinese Investigators! Great to see such an amazing 🌎 expansion of your footprint! @OncoAlert @PGrivasMDPhD @montypal @neerajaiims @TresUramigas @uromigosjapan
0
3
9
Improving diagnostic accuracy in preoperative glioma classification: performance of knowledge-enhanced large language models compared with radiologists | npj Precision Oncology
nature.com
npj Precision Oncology - Improving diagnostic accuracy in preoperative glioma classification: performance of knowledge-enhanced large language models compared with radiologists
0
7
11
Comprehensive characterization and targeted treatment of a pediatric epithelioid glioblastoma with a rare TRIM24-NTRK2 fusion | npj Precision Oncology
nature.com
npj Precision Oncology - Comprehensive characterization and targeted treatment of a pediatric epithelioid glioblastoma with a rare TRIM24-NTRK2 fusion
0
2
6
Disitamab vedotin (RC48-ADC) combined with immunotherapy as neoadjuvant therapy for localized muscle-invasive bladder cancer: a multicenter real-world study | npj Precision Oncology
nature.com
npj Precision Oncology - Disitamab vedotin (RC48-ADC) combined with immunotherapy as neoadjuvant therapy for localized muscle-invasive bladder cancer: a multicenter real-world study
0
1
6
Targeting high-risk MYC-overexpressed osteosarcoma with an Aurora kinase inhibitor:--results from a pilot umbrella trial | npj Precision Oncology
nature.com
npj Precision Oncology - Targeting high-risk MYC-overexpressed osteosarcoma with an Aurora kinase inhibitor:--results from a pilot umbrella trial
0
4
18
A single-cell atlas reveals the tumorigenesis and microenvironment status of primary tracheobronchial tumors | npj Precision Oncology
nature.com
npj Precision Oncology - A single-cell atlas reveals the tumorigenesis and microenvironment status of primary tracheobronchial tumors
1
2
4
Pan-cancer clinicopathological and genomic characteristics of peritoneal metastasis | npj Precision Oncology
nature.com
npj Precision Oncology - Pan-cancer clinicopathological and genomic characteristics of peritoneal metastasis
0
9
22
Liquid Biopsy and Solid Standards: Charting the Path to the Clinical Translation of Cerebrospinal Fluid Biomarkers | JCO Precision Oncology
ascopubs.org
1
10
15
Delta-Like Ligand 3 Expression and Functional Imaging in Gastroenteropancreatic Neuroendocrine Neoplasms | JCO Precision Oncology
ascopubs.org
PURPOSEDelta-like ligand 3 (DLL3) is an emerging target across neuroendocrine cancers, but remains underexplored in gastroenteropancreatic neuroendocrine neoplasms (GEP NENs), including poorly...
0
4
8
⭐️Understanding How Aspirin Prevents Metastasis @NEJM ⭐️A new study shows that aspirin enhances antimetastatic immunity by decreasing platelet activation, thereby releasing T cells from suppression by thromboxane A2.
nejm.org
A new study shows that aspirin enhances antimetastatic immunity by decreasing platelet activation, thereby releasing T cells from suppression by thromboxane A2.
1
25
94
Liquid biopsies across the cancer care continuum | Nature Medicine
nature.com
Nature Medicine - This Review summarizes current and emerging liquid biopsy methods, together with their clinical validity and utility, and highlights opportunities to support their implementation...
0
43
138
Rethinking Ribociclib Dosage and Use in the Era of Patient-Centered Oncology
jamanetwork.com
Hormone therapy (HT) remains the foundation of treatment for hormone receptor–positive breast cancer, both in the early-stage and metastatic settings. These therapies reliably reduce recurrence risk...
2
0
2
Lorlatinib in Tyrosine Kinase Inhibitor−Naive Advanced ROS1-Positive Non−Small Cell Lung Cancer
jamanetwork.com
This multicenter nonrandomized clinical trial evaluates the efficacy and safety of lorlatinib for patients with advanced ROS1-positive non−small cell lung cancer who have not been treated with a...
0
0
6
Predictive Role of Circulating Tumor DNA in Stage III Colon Cancer Treated With Celecoxib
jamanetwork.com
This prespecified post hoc analysis of a phase 3 randomized clinical trial investigates the predictive value of postoperative circulating tumor DNA for survival outcomes among patients with stage III...
0
1
12